Protagonist Therapeutics, Inc Capital Expenditures Incurred but Not yet Paid
Protagonist Therapeutics, Inc (PTGX) reported Capital Expenditures Incurred but Not yet Paid of $17.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-05
- Protagonist Therapeutics, Inc capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$93.00K, a 232.86% decline year-over-year.
- Protagonist Therapeutics, Inc capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $110.00K, a 233.33% increase year-over-year.
- Protagonist Therapeutics, Inc capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$95.00K, a 290.00% decline year-over-year.
- Protagonist Therapeutics, Inc capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $70.00K, a 69.57% decline year-over-year.
- Protagonist Therapeutics, Inc capital expenditures incurred but not yet paid for fiscal 2024 was $46.00K, a 24.59% decline from fiscal 2023.
- Protagonist Therapeutics, Inc capital expenditures incurred but not yet paid for fiscal 2023 was $61.00K, a 221.05% increase from fiscal 2022.
- Protagonist Therapeutics, Inc capital expenditures incurred but not yet paid for fiscal 2022 was $19.00K, a 86.71% decline from fiscal 2021.
- Protagonist Therapeutics, Inc capital expenditures incurred but not yet paid for fiscal 2021 was $143.00K, a 68.24% increase from fiscal 2020.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $17.00K 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $110.00K 10-Q · filed 2026-05-05 | |||
| 2025-09-30 | -$95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$25.00K derived: sum of 2 quarters · filed 2026-08-05 | $8.00K 10-Q · filed 2025-11-06 | -$271.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $103.00K 10-Q · filed 2026-08-05 | -$176.00K derived: sum of 3 quarters · filed 2026-08-05 | -$126.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $33.00K 10-Q · filed 2026-05-05 | -$246.00K derived: sum of 2 quarters · filed 2026-05-05 | -$196.00K derived: sum of 3 quarters · filed 2026-05-05 | $34.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$229.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.00K derived: sum of 3 quarters · filed 2026-02-25 | $46.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $280.00K derived: sum of 2 quarters · filed 2025-11-06 | $325.00K 10-Q · filed 2025-11-06 | $383.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $275.00K 10-Q · filed 2025-08-06 | $333.00K derived: sum of 3 quarters · filed 2026-02-25 | $275.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $45.00K 10-Q · filed 2025-05-06 | $103.00K derived: sum of 2 quarters · filed 2026-02-25 | $45.00K derived: sum of 3 quarters · filed 2026-02-25 | $91.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $46.00K derived: sum of 3 quarters · filed 2026-02-25 | $61.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | -$58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$12.00K derived: sum of 2 quarters · filed 2024-11-07 | $3.00K 10-Q · filed 2024-11-07 | -$39.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $61.00K 10-Q · filed 2024-08-06 | $19.00K derived: sum of 3 quarters · filed 2025-02-21 | -$42.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $15.00K 10-Q · filed 2024-05-07 | -$27.00K derived: sum of 2 quarters · filed 2025-02-21 | -$88.00K derived: sum of 3 quarters · filed 2025-02-21 | -$201.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$103.00K derived: sum of 2 quarters · filed 2025-02-21 | -$216.00K derived: sum of 3 quarters · filed 2025-02-21 | $19.00K 10-K · filed 2025-02-21 |
| 2022-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$174.00K derived: sum of 2 quarters · filed 2023-11-02 | $61.00K 10-Q · filed 2023-11-02 | $180.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $122.00K 10-Q · filed 2023-08-03 | $241.00K derived: sum of 3 quarters · filed 2024-02-27 | $202.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $235.00K 10-Q · filed 2023-05-04 | $354.00K derived: sum of 2 quarters · filed 2024-02-27 | $315.00K derived: sum of 3 quarters · filed 2024-02-27 | $281.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $80.00K derived: sum of 2 quarters · filed 2024-02-27 | $46.00K derived: sum of 3 quarters · filed 2024-02-27 | $143.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | -$39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$73.00K derived: sum of 2 quarters · filed 2022-11-08 | $24.00K 10-Q · filed 2022-11-08 | $82.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $63.00K 10-Q · filed 2022-08-04 | $121.00K derived: sum of 3 quarters · filed 2023-03-15 | $127.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | $97.00K 10-Q · filed 2022-05-05 | $155.00K derived: sum of 2 quarters · filed 2023-03-15 | $161.00K derived: sum of 3 quarters · filed 2023-03-15 | $177.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $64.00K derived: sum of 2 quarters · filed 2023-03-15 | $80.00K derived: sum of 3 quarters · filed 2023-03-15 | $85.00K 10-K · filed 2023-03-15 |
| 2020-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $22.00K derived: sum of 2 quarters · filed 2021-11-03 | $27.00K 10-Q · filed 2021-11-03 | -$30.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $21.00K 10-Q · filed 2021-08-04 | -$36.00K derived: sum of 3 quarters · filed 2022-02-28 | $39.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $5.00K 10-Q · filed 2021-05-04 | -$52.00K derived: sum of 2 quarters · filed 2022-02-28 | $23.00K derived: sum of 3 quarters · filed 2022-02-28 | -$544.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $18.00K derived: sum of 2 quarters · filed 2022-02-28 | -$549.00K derived: sum of 3 quarters · filed 2022-02-28 | $100.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$492.00K derived: sum of 2 quarters · filed 2020-11-04 | $157.00K 10-Q · filed 2020-11-04 | |
| 2019-06-30 | -$567.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $82.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $649.00K 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $24.00K 10-K · filed 2021-03-10 | |||
| 2018-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $8.00K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $36.00K 10-Q · filed 2019-05-08 | |||
| 2017-09-30 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$112.00K derived: sum of 2 quarters · filed 2018-11-06 | $6.00K 10-Q · filed 2018-11-06 | $27.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $42.00K 10-Q · filed 2018-08-07 | $63.00K derived: sum of 3 quarters · filed 2019-03-12 | $63.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $118.00K 10-Q · filed 2018-05-09 | $139.00K derived: sum of 2 quarters · filed 2019-03-12 | $139.00K derived: sum of 3 quarters · filed 2019-03-12 | $139.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $21.00K derived: sum of 2 quarters · filed 2019-03-12 | $21.00K derived: sum of 3 quarters · filed 2019-03-12 | $21.00K 10-K · filed 2019-03-12 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |